SCHEDULE 14A
                                 (Rule 14a-101)

                     INFORMATION REQUIRED IN PROXY STATEMENT

                            SCHEDULE 14A INFORMATION

           Proxy Statement Pursuant to Section 14(a) of the Securities
                      Exchange Act of 1934 (Amendment No. )

Filed by the Registrant |X|
Filed by a Party other than the Registrant o
Check the appropriate box:
o Preliminary Proxy Statement         o  Confidential, For Use of the Commission
                                         Only (as permitted by Rule 14a-6(e)(2))
|X| Definitive Proxy Statement
o Definitive Additional Materials
o Soliciting Material Pursuant to Rule 14a-11(c) or Rule 14a-12


                           Nu Skin Asia Pacific, Inc.
                (Name of Registrant as Specified in Its Charter)

    (Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check the appropriate box):
     |X| No fee required.
      o Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
     (1) Title of each class of securities to which transaction applies:

- --------------------------------------------------------------------------------


     (2) Aggregate number of securities to which transaction applies:

- --------------------------------------------------------------------------------


     (3) Per unit price or other  underlying  value of transaction  computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
is calculated and state how it was determined):

- --------------------------------------------------------------------------------


     (4) Proposed maximum aggregate value of transaction:

- --------------------------------------------------------------------------------


     (5) Total fee paid:

- --------------------------------------------------------------------------------


       o Fee paid previously with preliminary materials:

- --------------------------------------------------------------------------------


       o Check box if any part of the fee is offset as  provided  by  Exchange
Act Rule  0-11(a)(2)  and identify the filing for which the  offsetting  fee was
paid previously.  Identify the previous filing by registration statement number,
or the form or schedule and the date of its filing.

     (1) Amount previously paid:

- --------------------------------------------------------------------------------


     (2) Form, Schedule or Registration Statement no.:

- --------------------------------------------------------------------------------


     (3) Filing Party:

- --------------------------------------------------------------------------------


     (4) Date Filed:

- --------------------------------------------------------------------------------





- --------------------------------------------------------------------------------

                    NOTICE OF ANNUAL MEETING OF STOCKHOLDERS

                           TO BE HELD ON MAY 15, 1997
- --------------------------------------------------------------------------------

         NOTICE IS HEREBY GIVEN that the annual  meeting of  stockholders  of Nu
Skin Asia Pacific, Inc., a Delaware corporation (the "Company"), will be held at
the Provo Park Hotel, Provo, Utah, on Thursday, May 15, 1997 at 4:00 p.m., local
time (the "Annual Meeting"), for the following purposes:

         1. To elect a Board of  Directors  consisting  of eleven  directors  to
serve until the next annual meeting of  stockholders  or until their  successors
are duly elected and qualified on their earlier death or removal;

         2. To approve the  adoption of the Nu Skin Asia  Pacific,  Inc.  1996
Stock Incentive Plan;

         3. To ratify the appointment of Price  Waterhouse LLP,  independent
public accountants,  to audit the  financial  statements  of the Company for
the fiscal year ending December 31, 1997; and

         4. To transact  such other  business as may properly come before the
Annual Meeting or any adjournment(s) thereof.

         The Board of Directors has fixed the close of business on April 1, 1997
as the record date (the "Record Date") for determining the stockholders entitled
to receive notice of, and to vote at, the Annual Meeting and any  adjournment(s)
thereof.

ALL STOCKHOLDERS  ARE CORDIALLY  INVITED TO ATTEND THE ANNUAL MEETING IN PERSON.
HOWEVER, TO ENSURE YOUR  REPRESENTATION AT THE ANNUAL MEETING,  YOU ARE URGED TO
MARK,  SIGN,  DATE AND RETURN THE ENCLOSED  PROXY AS PROMPTLY AS POSSIBLE IN THE
POSTAGE-PREPAID  ENVELOPE ENCLOSED FOR THAT PURPOSE.  ANY STOCKHOLDER  ATTENDING
THE ANNUAL  MEETING MAY VOTE IN PERSON EVEN IF SUCH  STOCKHOLDER  HAS PREVIOUSLY
RETURNED A PROXY.

                                             By Order of the Board of Directors



                                             Blake M. Roney
                                             Chairman of the Board

Provo, Utah, April 7, 1997




- --------------------------------------------------------------------------------

                                 PROXY STATEMENT

                         ANNUAL MEETING OF STOCKHOLDERS
                           TO BE HELD ON MAY 15, 1997
- --------------------------------------------------------------------------------

                 INFORMATION CONCERNING SOLICITATION AND VOTING

General

     The  enclosed  Proxy is solicited on behalf of the Board of Directors of Nu
Skin Asia Pacific, Inc., a Delaware corporation (the "Company"),  for use at the
annual  meeting of  stockholders  to be held on  Thursday,  May 15, 1997 at 4:00
p.m., local time, and at any adjournment(s) thereof (the "Annual Meeting"),  for
the purposes set forth herein and in an accompanying Notice of Annual Meeting of
Stockholders.  The Annual  Meeting will be held at the Provo Park Hotel,  Provo,
Utah.

     As used herein, the "Company" means Nu Skin Asia Pacific,  Inc.,  including
the  Subsidiaries.  The  "Subsidiaries"  means Nu Skin Hong Kong, Inc. ("Nu Skin
Hong Kong"),  Nu Skin Japan Company,  Limited ("Nu Skin Japan"),  Nu Skin Korea,
Inc. ("Nu Skin Korea"),  Nu Skin Taiwan,  Inc. ("Nu Skin  Taiwan"),  and Nu Skin
Personal Care (Thailand) Limited ("Nu Skin Thailand"), collectively.

Record Date and Share Ownership

     Stockholders  of  record  at the  close of  business  on April 1, 1997 (the
"Record Date") are entitled to vote at the Annual  Meeting.  At the Record Date,
11,723,011  shares of the Company's  Class A Common  Stock,  $.001 par value per
share  ("Class A Common  Stock"),  71,696,675  shares of the  Company's  Class B
Common Stock,  $.001 par value per share ("Class B Common Stock," and,  together
with the  Class A Common  Stock,  the  "Common  Stock"),  and -0-  shares of the
Company's Preferred Stock ("Preferred Stock") were issued and outstanding. Since
no shares of Preferred Stock are  outstanding,  no shares of Preferred Stock are
entitled to vote at the Annual Meeting.  Stockholders of record holding at least
a majority  of the  outstanding  shares of Common  Stock,  present at the Annual
Meeting in person or by proxy,  shall constitute a quorum for the transaction of
business at the Annual Meeting.

Revocability of Proxies

     Any Proxy given pursuant to this  solicitation may be revoked by the person
or entity giving it at any time before its use by delivering to the Secretary of
the Company a written  notice of revocation  or a duly executed  Proxy bearing a
later date or by attending  the Annual  Meeting and voting in person;  provided,
however,  that  such  action  must be taken in  sufficient  time to  permit  the
necessary  examination  and  tabulation  of the  revocation or later dated Proxy
before the vote is taken.  An  appointment of proxy is revoked upon the death or
incapacity of the  stockholder  if the Secretary or other officer of the Company
who is authorized to tabulate votes receives  notice of such death or incapacity
before the proxy exercises his authority under the appointment.

Voting and Solicitation

     Each outstanding share of Class A Common Stock shall be entitled to one (1)
vote and each outstanding share of Class B Common Stock shall be entitled to ten
(10) votes on each matter  submitted to a vote of the stockholders at the Annual
Meeting.  The Class A Common  Stock and the Class B Common  Stock will vote as a
single class with respect to all matters submitted to a vote of the stockholders
at the Annual  Meeting.  A quorum  represented  by a majority  of the issued and
outstanding  shares of Common  Stock of record  present in person or by proxy is
necessary  to  conduct  the Annual  Meeting.  Assuming  a quorum is  present,  a
plurality  of votes  cast by the  shares  entitled  to vote in the  election  of
directors  will be  required  to elect  each  director.  In all  other  matters,
assuming a quorum is present,  a majority of votes cast by the shares present in
person or by proxy and entitled to vote on the subject  matter shall decide such
matter,  except when a different  vote is required by express  provision  of the
Delaware General Corporation Law, the Company's  Certificate of Incorporation or
the Company's Bylaws.  In accordance with Delaware law,  abstentions will, while
broker  nonvotes  will not, be treated as present for the purposes of voting.  A
broker  nonvote is a proxy  submitted  by a broker in which the broker  fails to
vote on behalf of a client on a particular  matter for lack of instruction  when
such instruction is required by the New York Stock Exchange.

     All Proxies,  properly  executed and returned,  will be voted at the Annual
Meeting as directed by the  stockholder.  Please vote by marking the appropriate
boxes on the  enclosed  Proxy.  If the  Proxy is  signed  and  returned  without
directions,  the shares will be voted "FOR" the  election  of all  directors  as
nominated,  "FOR" the approval of the adoption of the Nu Skin Asia Pacific, Inc.
1996 Stock  Incentive  Plan, and "FOR" the  ratification  of the  appointment of
Price Waterhouse LLP,  independent  public  accountants,  to audit the financial
statements of the Company for the fiscal year ending December 31, 1997. If other
matters properly come before the meeting, the shares will be voted in accordance
with the best judgment of the persons named as proxies on the Proxy.  Any shares
not voted "FOR" a  particular  director  as a result of a direction  to withhold
authority or a broker nonvote will not be counted in the director's favor.

     These  proxy  solicitation  materials  were first sent or given on or about
April 7, 1997 to all  stockholders  listed  in the  stockholder  records  of the
Company as of the Record Date.  The principal  executive  offices of the Company
are located at 75 West Center  Street,  Provo,  Utah  84601,  and the  Company's
telephone  number  is  (801)  345-6100.  The  Company  will  bear  the  cost  of
solicitation  of proxies.  In  addition to the use of the mails,  proxies may be
solicited  personally,  by  telephone  or by  facsimile,  and  the  Company  may
reimburse  brokerage  firms and other persons  holding  shares of Class A Common
Stock  and/or  Class B  Common  Stock in  their  names or in the  names of their
nominees, for their reasonable expenses in forwarding proxy soliciting materials
to the beneficial owners.

Deadline for Receipt of Stockholder Proposals

     Proposals of  stockholders  of the Company  intended to be presented at the
Company's 1998 annual meeting of stockholders  must be received by the Secretary
of the Company at the Company's  principal executive offices by December 2, 1997
in order to be included in the Proxy Statement and form of proxy relating to the
1998 annual meeting of stockholders.  The Company currently anticipates that the
1998 annual meeting of stockholders will be held in April 1998.

Matters to Be Brought Before the Annual Meeting

     The  matters to be  brought  before the  Annual  Meeting  include:  (i) the
election  of a Board of  Directors  consisting  of  eleven  directors;  (ii) the
approval of the adoption of the Nu Skin Asia Pacific,  Inc. 1996 Stock Incentive
Plan;  (iii)  the  ratification  of the  appointment  of Price  Waterhouse  LLP,
independent public accountants, to audit the financial statements of the Company
for the fiscal year ending  December 31, 1997; and (iv) the  transaction of such
other business as may properly come before the Annual Meeting.

                                     ITEM 1
                              ELECTION OF DIRECTORS

Nominees

     The Company's Board of Directors currently consists of eleven directors. It
is proposed that a board of eleven  directors be elected at the Annual  Meeting.
In the event  that any  director  nominee  is unable or  declines  to serve as a
director  at the time of the  Annual  Meeting,  the proxy  holder  will vote the
Proxies  received by him for any nominee who shall be  designated by the current
Board of Directors to fill the vacancy. In the event that additional persons are
nominated  for  election  as  directors,  the proxy  holder  intends to vote all
Proxies  received by him in such a manner as will ensure the election of as many
of the nominees  listed below as possible.  It is not expected  that any nominee
will be unable or will  decline  to serve as a  director.  The term of office of
each person elected as a director will continue until the next annual meeting of
stockholders,  or until  such  person's  successor  has been  duly  elected  and
qualified  or such  person's  earlier  death or  removal.  The  nominees  are as
follows:

                                   Blake M. Roney
                                   Steven J. Lund
                                   Sandie N. Tillotson
                                   Brooke B. Roney
                                   Kirk V. Roney
                                   Keith R. Halls
                                   Max E. Esplin
                                   Max L. Pinegar
                                   E.J. "Jake" Garn
                                   Paula Hawkins
                                   Daniel W. Campbell


     Each of the  nominees is  currently  serving as a director of the  Company.
Certain information regarding each nominee is set forth hereinbelow.

THE BOARD OF DIRECTORS  RECOMMENDS  A VOTE "FOR" EACH OF THE ELEVEN  NOMINEES TO
THE COMPANY'S  BOARD OF  DIRECTORS.  A PLURALITY OF THE VOTES CAST BY THE SHARES
ENTITLED TO VOTE AT THE ANNUAL MEETING WILL BE REQUIRED TO ELECT EACH DIRECTOR.

Directors and Executive Officers

        As of March 3, 1997, the directors and executive officers of the Company
and key managers of the Subsidiaries were as follows:

    Name                         Age         Position

    Blake M. Roney               38          Chairman of the Board
    Steven J. Lund               43          President, Chief Executive Officer
                                                and Director
    Renn M. Patch                46          Chief Operating Officer
    Corey B. Lindley             32          Vice President of Finance
    Michael D. Smith             51          Vice President of Operations
    M. Truman Hunt               37          Vice President of Legal Affairs
                                                and Investor Relations
    Keith R. Halls               39          Secretary and Director
    Takashi Bamba                61          President, Nu Skin Japan
    John Chou                    50          President, Nu Skin Taiwan
    S.T. Han                     54          President, Nu Skin Korea
    George Mak                   43          President, Nu Skin Hong Kong
    Sandie N. Tillotson          40          Director
    Brooke B. Roney              34          Director
    Kirk V. Roney                42          Director
    Max L. Pinegar               65          Director
    Max E. Esplin                53          Director
    E.J. "Jake" Garn             64          Director
    Paula Hawkins                70          Director
    Daniel W. Campbell           42          Director
- ---------------------

      A  brief  biographical  summary  of each of the  Company's  directors  and
executive officers and the key managers of the Subsidiaries follows:

     Blake M. Roney has served as the Chairman of the Board since the  Company's
inception  and is a founder of Nu Skin  International  Inc., an affiliate of the
Company ("NSI").  He has also served as President,  Chief Executive  Officer and
Chairman of the Board of NSI and certain of its affiliated  entities since their
respective inceptions.  He received a B.S. degree from Brigham Young University.
He is the brother of Kirk V. Roney and Brooke B. Roney.

     Steven  J.  Lund has been the  President,  Chief  Executive  Officer  and a
Director  of the  Company  since  its  inception.  Mr.  Lund has also  served as
Executive  Vice President and a Director of NSI since 1985 and as Vice President
and  Secretary  of  certain  NSI  affiliated  entities  since  their  respective
inceptions.  Mr. Lund previously worked as an attorney in private  practice.  He
received a B.A.  degree from Brigham  Young  University  and a J.D.  degree from
Brigham Young University's J. Reuben Clark Law School.

     Renn M. Patch has been the Chief Operating Officer of the Company since its
inception.  Since  1992 he has been  Vice  President  of Global  Operations  and
Assistant  General  Manager of NSI.  From 1991 to 1992, he served as Director of
Government  Affairs  of NSI.  Prior  to  joining  NSI in  1991,  Mr.  Patch  was
associated  with  the  Washington,  D.C.  consulting  firm of Parry  and  Romani
Associates.  Mr. Patch earned a B.A. degree from the University of Minnesota,  a
J.D.  degree from  Hamline  University  School of Law and an L.L.M.  degree from
Georgetown University.

     Corey B.  Lindley  has been the Vice  President  of Finance of the  Company
since  its  inception.  From  1993 to 1996,  he  served  as  Managing  Director,
International of NSI. Mr. Lindley worked as the International  Controller of NSI
from 1991 to 1994 and lived in Hong Kong and Japan  during that time.  From 1990
to 1991,  he served as Assistant  Director of Finance of NSI.  Mr.  Lindley is a
Certified  Public  Accountant.  Prior to joining NSI in 1990,  he worked for the
accounting  firm of Deloitte  and Touche.  He earned a B.S.  degree from Brigham
Young University and an M.B.A. degree from Utah State University.

      Michael D. Smith has been the Vice President of Operations for the Company
since its inception. He has also served as Vice President of Asian Operations of
NSI since February 1996. Prior to that time, he served as General Counsel of NSI
from 1992 to 1996 and as Director of Legal  Affairs of NSI from 1989 to 1992. He
earned B.S. and M.A.  degrees from Brigham Young  University  and a J.D.  degree
from the University of Utah.

      M.  Truman  Hunt has served as the Vice  President  of Legal  Affairs  and
Investor Relations since the Company's inception.  He has also served as Counsel
to the  President  of NSI since  1994.  From 1991 to 1994,  Mr.  Hunt  served as
President and Chief Executive  Officer of Better Living  Products,  Inc., an NSI
affiliate  involved in the  manufacture and  distribution of houseware  products
sold  through  traditional  retail  channels.  Prior  to  that  time,  he  was a
securities and business attorney in private practice.  He received a B.S. degree
from Brigham Young University and a J.D. degree from the University of Utah.

     Keith R. Halls has served as the  Secretary  and a Director  of the Company
since its inception. He has also served as General Vice President and a Director
of NSI since  1992.  He served as  Director of Finance of NSI from 1986 to 1992.
Mr. Halls is a Certified  Public  Accountant.  Mr. Halls received a B.A.  degree
from Stephen F. Austin State  University  and a B.S.  degree from Brigham  Young
University.

     Takashi Bamba has served as the President and/or General Manager of Nu Skin
Japan since 1993.  Prior to joining Nu Skin Japan in 1993, Mr. Bamba served five
years as President  and CEO of Avon  Products  Co.,  Ltd.,  the publicly  traded
Japanese  subsidiary of Avon  Products,  Inc.  Prior to working at Avon Products
Co.,  Ltd., he spent 17 years at Avon Products,  Inc. He received a B.A.  degree
from Yokohama National University.

      John Chou has served as the President  and/or  General  Manager of Nu Skin
Taiwan since 1991.  Prior to joining Nu Skin Taiwan in 1991, he spent twenty-one
years in  international  marketing  and  management  with 3M Taiwan Ltd.,  Amway
Taiwan and  Universal  PR Co. Mr. Chou is a standing  director of the Taiwan ROC
Direct Selling  Association.  He is also a member of the Kiwanis  International,
and the Taiwan American Chamber of Commerce.  He received a B.A. degree from Tan
Kang University in Taipei, Taiwan.

     S.T.  Han has served as the  President  and/or  General  Manager of Nu Skin
Korea  since  1995.  Prior to joining Nu Skin Korea in 1995,  Mr. Han spent four
years as the  Executive  Managing  Director of Woosung Film Co.,  the  exclusive
distributor of Konica film in South Korea. He also worked for Amway Korea,  Ltd.
during that  Company's  start-up  phase of operations in 1991. Mr. Han graduated
with a B.A. degree from ChungAng University.

      George Mak has served as the President  and/or General  Manager of Nu Skin
Hong Kong since 1991. Prior to joining Nu Skin Hong Kong in 1991, Mr. Mak worked
for Johnson & Johnson as a personnel  and  administration  manager for Hong Kong
and Shanghai from 1989 to 1991. Prior to joining Johnson & Johnson he worked for
10 years in the  human  resources  and  accounting  fields.  He earned an M.B.A.
degree from the University of East Asia, Macau.

      Sandie N.  Tillotson  has served as a Director  of the  Company  since its
inception.  She was a  founder  of NSI and  has  also  served  as  General  Vice
President since 1992 and a Director of NSI since its inception and as a Director
and an executive  officer of certain of NSI's  affiliated  entities  since their
respective inceptions. She served as Vice President of Corporate Services of NSI
from 1984 to 1992. She earned a B.S. degree from Brigham Young University.

      Brooke  B.  Roney  has  served  as a  Director  of the  Company  since its
inception. He was a founder of NSI and has also served as General Vice President
and a Director of NSI since 1992 and as a Director and an  executive  officer of
certain of NSI's  affiliated  entities  since their  respective  inceptions.  He
served as Vice President of Distribution of NSI from 1984 to 1992.
He is the brother of Blake M. Roney and Kirk V. Roney.

     Kirk V. Roney has served as a Director of the Company since its  inception.
He has also served as General Vice President of NSI since 1992 and a Director of
NSI since 1984 and as a Director  and an  executive  officer of certain of NSI's
affiliated  entities  since  their  respective  inceptions.  He  served  as Vice
President of Planning  and  Development  of NSI from 1984 to 1992.  He earned an
M.I.M. degree from the American Graduate School of International  Management. He
earned an M.A. degree from Central  Michigan  University and a B.A. from Brigham
Young University. He is the brother of Blake M. Roney and Brooke B. Roney.

     Max L.  Pinegar  has served as a Director of the  Company  since  September
1996.  He has also  served as  General  Manager  of NSI  since  1989 and as Vice
President  of NSI since 1992.  He  received a B.A.  degree  from  Brigham  Young
University and an M.B.A. degree from the University of Utah.

     Max E. Esplin has served as a Director of the Company since September 1996.
He has also served as Vice  President of Finance of NSI since 1993. He served as
Controller  of NSI from  1989  until  1993.  Mr.  Esplin is a  Certified  Public
Accountant. He received a B.S. degree from Brigham Young University.

      E.J. "Jake" Garn has served as a Director of the Company since March 1997.
Senator Garn has been Vice Chairman of Huntsman Corporation,  one of the largest
privately-held  companies  in the U.S.,  since 1993.  He  currently  serves as a
director for Dean Witter Funds,  John Alden Life Insurance  Company and Franklin
Quest & Co.,  Inc.  From 1974 to 1993,  Senator  Garn was a member of the United
States  Senate and served on  numerous  senate  committees.  He  received a B.A.
degree from the University of Utah.

      Paula  Hawkins has served as a Director  of the Company  since March 1997.
Senator  Hawkins  is the  principal  of Paula  Hawkins  &  Associates,  Inc.,  a
management  consulting company.  From 1980 to 1986, Senator Hawkins was a member
of the United States Senate and served on numerous senate committees.

     Daniel W.  Campbell  has served as a Director  of the  Company  since March
1997.  Mr.  Campbell has been a Managing  General  Partner of EsNet,  Ltd. since
1994.  From 1992 to 1994,  Mr.  Campbell was the Senior Vice President and Chief
Financial Officer of WordPerfect  Corporation and prior to that was a Partner of
Price Waterhouse LLP. He received a B.S. degree from Brigham Young University.

Committees of the Board of Directors

     In  January  and March  1997,  the  Board of  Directors  established  three
additional committees:  the Audit Committee,  the Compensation Committee and the
Executive Committee.

     The Audit  Committee  members are Daniel W. Campbell and E.J.  "Jake" Garn.
Mr. Campbell is the Chairman of the Audit Committee. The Audit Committee,  among
other  things,  makes  recommendations  to the Board of Directors  regarding the
selection of  independent  certified  public  accountants  to audit annually the
books and records of the Company,  reviews the activities and the reports of the
independent certified public accountants,  reports the results of such review to
the Board of Directors  and  considers  the adequacy of the  Company's  internal
controls and internal auditing methods and procedures.

     The  Compensation  Committee  members are Keith R. Halls,  Max L.  Pinegar,
Paula  Hawkins  and  Daniel  W.  Campbell.  Mr.  Halls  is the  Chairman  of the
Compensation Committee.  The Compensation  Committee,  among other things, makes
recommendations  to the Board of Directors  regarding the salaries,  bonuses and
other compensation to be paid to the Company's officers.

     The  Executive  Committee  members are Blake M.  Roney,  Steven J. Lund and
Keith R. Halls. Mr. Roney is the Chairman of the Executive Committee. The duties
of the  Executive  Committee  are,  to the  extent  authorized  by the  Board of
Directors,  to exercise  all the powers and  authority of the Board of Directors
with respect to the management of the business and affairs of the Company.

Meetings

      In the fiscal year ended  December 31, 1996,  the Board of Directors  held
four  meetings,  three  of  which  were  held  by  written  consent.  All of the
then-current  members  of the Board of  Directors  attended  the  meetings.  The
Compensation  Committee,  the Audit  Committee and the Executive  Committee were
each  formed in 1997 and  therefore  held no  meetings  in the fiscal year ended
December 31, 1996.

Compensation of Directors

      Directors who do not receive  compensation as officers or employees of the
Company,  NSI or its  affiliates  are paid an annual fee of $25,000 and a fee of
$1,000  for each  meeting of the Board of  Directors  or any  committee  meeting
thereof that they attend.


                                     ITEM 2
                           APPROVAL OF ADOPTION OF THE
              NU SKIN ASIA PACIFIC, INC. 1996 STOCK INCENTIVE PLAN

General

      In  connection  with the  Company's  initial  public  offering,  which was
consummated  on November  27, 1996,  the Board of Directors  adopted the Nu Skin
Asia Pacific,  Inc. 1996 Stock  Incentive Plan (the "Plan").  The purpose of the
Plan  is  to  attract  and  retain  executives,  other  employees,   independent
consultants  and  directors  who are  important to the success and growth of the
Company and to ensure that their interests are aligned with the interests of the
stockholders of the Company.  The following summary of the material terms of the
Plan,  a copy of which is  attached  hereto as Exhibit A, does not purport to be
complete and is qualified in its entirety by the terms of the Plan.

THE BOARD OF DIRECTORS RECOMMENDS A VOTE "FOR" THE PROPOSAL TO
APPROVE THE ADOPTION OF THE NU SKIN ASIA PACIFIC, INC. 1996 STOCK
INCENTIVE PLAN.  A MAJORITY OF THE VOTES CAST BY THE SHARES
ENTITLED TO VOTE AT THE ANNUAL MEETING WILL BE REQUIRED TO
APPROVE THE PROPOSAL.

Plan Administration

      The Plan is  administered  by the 1996 Stock Incentive Plan Committee (the
"Plan   Committee").   The  Plan  Committee  consists  of  the  members  of  the
Compensation Committee of the Board of Directors. The Plan Committee determines,
from time to time,  the  individuals  to whom awards shall be made,  the type of
awards,  and the amount,  size and terms of each award. The Plan Committee makes
all other  determinations  necessary or advisable for the  administration of the
Plan.

Awards

      Awards  under the Plan may be in the form of  options  (both  nonqualified
stock options ("NQSOs") and incentive stock options ("ISOs")), contingent stock,
restricted stock, and stock appreciation rights ("SARs"), or such other forms as
the Plan Committee in its discretion may deem appropriate. The maximum number of
awards that may be issued to any one person during the life of the Plan shall be
limited to 10% of the shares reserved for issuance under the Plan. The number of
shares  which  may be  issued  under  the  Plan  as  well  as the  terms  of any
outstanding  awards may be equitably adjusted by the Plan Committee in the event
of a stock  split,  stock  dividend,  recapitalization,  merger,  consolidation,
combination or similar  events.  In general,  any shares subject to an option or
right which for any reason expires or is terminated  unexercised  shall again be
available under the Plan. No awards may be granted more than ten years after the
effective date of the Plan.

Number of Shares

      A total  of  4,000,000  shares  of the  Class A  Common  Stock  have  been
authorized to be issued  pursuant to the Plan. As of March 3, 1997,  the Company
had made stock bonus  awards to certain of its  employees  for an  aggregate  of
150,959  shares of Class A Common  Stock.  The  shares  of Class A Common  Stock
underlying  each of these stock bonus awards will be issued to the  recipient of
the award at a rate of 25% per year  commencing in November  1997,  provided the
employee remains in the employment of the Company.

Plan Amendment

      The Board of Directors may amend the Plan, without  stockholder  approval,
anytime in any respect unless stockholder  approval of the amendment in question
is required under Delaware law, the Code,  certain exemptions from Section 16 of
the  Securities  Exchange  Act of 1934,  as  amended,  any  national  securities
exchange  system  on which  the  shares  are then  listed  or  reported,  by any
regulatory  body  having  jurisdiction  with  respect  to  the  Plan,  or  other
applicable  laws,  rules or  regulations.  No amendment to the Plan may alter or
impair any award  granted  under the Plan  without  the  consent of the  holders
thereof. The Plan may be terminated at any time by the Board of Directors.

Options

     The Plan provides for the grant of ISOs to employees and NQSOs to employees
and  independent  consultants.  In the case of ISOs,  the  exercise  price of an
option may not be less than 100% of the fair market  value of a share of Class A
Common  Stock at the time of grant  (or 110% of such  fair  market  value if the
optionee  owns more than 10% of the total voting power of all classes of Company
stock  outstanding  at the time of grant).  In the case of NQSOs,  the  exercise
price of an option may not be less than 85% of the fair market  value of a share
of Class A Common Stock at the time of grant. The Plan Committee may provide for
a reduction  in the  exercise  price of a NQSO by  dividends  paid on a share of
Class A Common Stock while the NQSO is outstanding.  Options will be exercisable
for a term  determined by the Plan Committee  provided such exercise shall occur
not  earlier  than six months and not later  than ten years  (five  years if the
optionee  owns more than ten percent of the total voting power of all classes of
Company Stock  outstanding  at the time of grant) after the grant of the option.
The  aggregate  fair  market  value of ISO's  (determined  at the time of grant)
granted to an employee  which may become first  exercisable  in any one calendar
year shall not exceed $100,000. If any option is not granted, exercised, or held
pursuant to the provisions  applicable to an ISO, it will be considered to be an
NQSO to the  extent  that  any or all of the  grant  is in  conflict  with  such
provisions.  The  Plan  Committee  has  the  power  to  permit  acceleration  of
previously  determined exercise terms under certain  circumstances and upon such
terms and conditions as the Plan Committee deems appropriate.

Contingent Stock

      The Plan  Committee  will  determine the amount of contingent  stock to be
granted to a participant  based on the past or expected  impact the  participant
has had or can have on the financial well being of the Company and other factors
determined by the Plan Committee to be appropriate.  A participant  receiving an
award of  contingent  stock  will  receive  the stock upon the  satisfaction  of
certain  objectives.  Contingent  stock awards made pursuant to the Plan will be
subject to such terms,  conditions  and  restrictions,  including  obtainment of
performance  objectives,  for such period or periods as may be determined by the
Plan  Committee at the time of grant.  The Plan  Committee in its discretion may
permit acceleration of the expiration of the applicable  restriction period with
respect to part or all of the award to any participant.

Restricted Stock

      The Plan  Committee  will  determine the amount of restricted  stock to be
granted to a participant  based on the past or expected  impact the  participant
has had or can have on the financial well being of the Company and other factors
deemed by the Plan Committee to be  appropriate.  Restricted  stock is issued to
the  participant  subject  to  forfeiture  if  certain  objectives  are not met.
Restricted stock awards made pursuant to the Plan shall be subject to the terms,
conditions and  restrictions,  including the payment of performance  objectives,
and for such period or periods as will be  determined  by the Plan  Committee at
the time of grant. The Plan Committee in its discretion may permit  acceleration
of the expiration of the applicable  restriction  period with respect to part or
all of the award to any participant. Shares of restricted stock may not be sold,
assigned, transferred, pledged, hypothecated or otherwise disposed of, except by
will or the laws of descent and  distribution,  for such period  provided in the
participant's award agreement.

SARs

      SARs  are  rights  to  receive  cash or  shares  of  Company  stock,  or a
combination  thereof,  as the Plan Committee may determine in an amount equal to
the excess of (i) the fair market  value of the stock with  respect to which the
SAR is  exercised,  or (ii) 100% of the fair  market  value of such stock at the
time the SAR was granted,  less any dividends  paid on such shares while the SAR
was outstanding.  No cash  consideration will be received by the Company for the
grant of any SAR.  No SAR may be  granted  for a period of less than one year or
greater  than ten years.  SARs may be exercised at such time and subject to such
terms and  conditions  as are  prescribed  by the Plan  Committee at the time of
grant,  subject  to  certain  limitations   (including  that  no  SAR  shall  be
exercisable within one year after the date of grant).

Federal Income Tax Consequences

      The participant recognizes no taxable gain or loss when an incentive stock
option is granted or exercised.  If the shares  acquired upon the exercise of an
incentive  stock  option are held for at least one year after  exercise  and two
years after grant (the "Holding Period"), the participant recognizes any gain or
loss recognized upon such sale as long-term capital gain or loss and the Company
is not  entitled  to a  deduction.  If the shares  are not held for the  Holding
Period,  the gain is  ordinary  income to the  participant  to the extent of the
difference  between the exercise  price and the fair market value of the Class A
Common Stock on the date the option is exercised and any excess is capital gain.
Also, in such circumstances, the Company is entitled to a deduction equal to the
amount of any ordinary income recognized by the participant.

      The participant  recognizes no taxable income and the Company  receives no
deduction  when a  nonqualified  stock  option is  granted.  Upon  exercise of a
nonqualified  stock option, the participant  recognizes  ordinary income and the
Company is entitled to a deduction equal to the difference  between the exercise
price  and the fair  market  value of the  shares on the date of  exercise.  The
participant  recognizes as a capital gain or loss any subsequent  profit or loss
realized on the sale or exchange of any shares disposed of or sold.

      A participant granted restricted stock or contingent stock is not required
to  include  the  value of such  shares in  income  until  the  first  time such
participant's  rights in the  shares  are  transferable  or are not  subject  to
substantial  risk  of  forfeiture,   whichever   occurs  earlier,   unless  such
participant timely files an election under Code Section 83(b) to be taxed on the
receipt of the shares.  In either case, the amount of such ordinary  income will
be equal to the  excess of the fair  market  value of the shares at the time the
income is recognized  over the amount (if any) paid for the shares.  The Company
is entitled to a deduction,  in the amount of the ordinary income  recognized by
the  participant,  for the  Company's  taxable  year in  which  the  participant
recognizes such income.

      Upon the grant of an SAR, the participant recognizes no taxable income and
the Company receives no deduction.  The participant  recognizes  ordinary income
and the Company is entitled to a deduction at the time of exercise  equal to the
cash and the fair market value of shares payable upon such exercise.

      Under certain  circumstances,  an accelerated vesting or cash out of stock
options,  or accelerated  lapse of restrictions  on other awards,  in connection
with a change in control  of the  Company  might be deemed an "excess  parachute
payment" for purposes of the golden  parachute  tax  provisions  of Code Section
280G. To the extent it is so considered, the participant may be subject to a 20%
excise tax and the Company may be denied a tax deduction.

Awards Made Under the Plan

      The following table sets forth certain  information  regarding stock bonus
awards made pursuant to the Plan to the executive  officers named in the Summary
Compensation table during the fiscal year ended December 31, 1996.


                                                                   Future
                                                                   Payouts
                                                                 (Number of
                                 Number of                        Shares of
                                 Shares of                         Class A
                                  Class A                          Common
                               Common Stock     Time Period        Stock)
Name                                (#)         Until Payout        (#)
- ----                               -----        ------------      --------
Steven J. Lund................      --              --               --
Takashi Bamba.................  13,000(1)      November 2000       13,000
John Chou.....................  13,000(1)      November 2000       13,000
Michael D. Smith..............  13,000(1)      November 2000       13,000
Renn M. Patch.................  13,000(2)      November 2000       13,000

- ---------------------------

(1)       Award made in November  1996,  which will vest ratably over four years
          from the date of grant provided the executive  officer  remains in the
          employment of the Company.
(2)       Award made in November  1996,  pursuant to the Nu Skin  International,
          Inc.  1996 Stock  Incentive  Plan,  which will vest  ratably over four
          years from the date of grant provided the executive officer remains in
          the employment of NSI. In 1996, Mr. Patch was, and continues to be, an
          executive officer of NSI.

                                     ITEM 3
               RATIFICATION OF APPOINTMENT OF PRICE WATERHOUSE LLP

      The Board of Directors has appointed  Price  Waterhouse  LLP,  independent
public accountants,  to audit the Company's financial  statements for the fiscal
year ending  December  31, 1997.  Representatives  of Price  Waterhouse  LLP are
expected to be present at the Annual  Meeting,  and will have the opportunity to
make a statement if they desire,  and are expected to be available to respond to
appropriate  questions.  Price  Waterhouse  LLP  has  served  as  the  Company's
independent public accountants since the Company's inception.

THE  BOARD  OF  DIRECTORS  RECOMMENDS  A  VOTE  "FOR"  THE  RATIFICATION  OF THE
APPOINTMENT OF PRICE WATERHOUSE LLP TO AUDIT THE COMPANY'S FINANCIAL  STATEMENTS
FOR THE FISCAL YEAR ENDING  DECEMBER  31,  1997. A MAJORITY OF THE VOTES CAST BY
THE SHARES  ENTITLED TO VOTE AT THE ANNUAL  MEETING  WILL BE REQUIRED TO APPROVE
THE PROPOSAL.

                                     ITEM 4
                                  OTHER MATTERS

      The Board of Directors  knows of no other matters to be brought before the
Annual Meeting. If other matters are properly brought before the Annual Meeting,
it is intended  that the persons  named in the enclosed  form of Proxy will have
discretionary  authority to vote on such matters in  accordance  with their best
judgment acting together or separately.


               SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND
                                   MANAGEMENT

      The  following  table  sets  forth  certain   information   regarding  the
beneficial  ownership of the  Company's  Class A Common Stock and Class B Common
Stock  as of  December  31,  1996 by (i) each  person  (or  group of  affiliated
persons)  who is known by the  Company to own  beneficially  more than 5% of the
outstanding  shares  of either  the  Class A Common  Stock or the Class B Common
Stock,  (ii)  each of the  Company's  directors,  (iii)  each  of the  Company's
executive  officers whose names appear in the summary  compensation  table under
the caption  "Compensation  of Directors and Executive  Officers,"  and (iv) all
executive  officers  and  directors  and  director  nominees of the Company as a
group. The information in this table assumes (a) the exercise of all the options
to purchase shares of Class A Common Stock (the  "Distributor  Options") offered
in the  Company's  non-underwritten  offering (the "Rule 415  Offerings")  which
commenced in connection  with the Company's  initial  public  offering,  (b) the
issuance of the 109,000  stock bonus  awards  offered by the Company in the Rule
415 Offerings and the shares of Class A Common Stock underlying such stock bonus
awards,  (c) the issuance of the 1,250,000 stock bonus awards offered by NSI and
its affiliates excluding the Company in the Rule 415 Offerings and the shares of
Class A Common Stock underlying such stock bonus awards, and (d) the exercise by
an executive  officer of the Company of an option to purchase  250,825 shares of
Class A Common Stock.  The business  address of the 5%  stockholders  is 75 West
Center Street, Provo, Utah, 84601.

                                                                           

                                       Class A                     Class B          Voting
                                   Common Stock(1)            Common Stock(1)        Power
    Directors, Executive
 Officers, 5% Stockholders        Number      %             Number        %            %
 -------------------------        ------     ----           ------       ----        -----
Blake M. Roney(2)                     --       --         20,629,048     28.8         28.2
Nedra D. Roney(3)                     --       --         14,213,895     19.8         19.5
Sandie N. Tillotson(4)                --       --          8,559,510     11.9         11.7
Craig S. Tillotson(5)                 --       --          4,411,057      6.2          6.0
R. Craig Bryson(6)                    --       --          4,925,736      6.9          6.7
Steven J. Lund(7)                     --       --          4,244,653      5.9          5.8
Brooke B. Roney(8)                    --       --          3,496,752      4.9          4.8
Kirk V. Roney(9)                      --       --          3,246,752      4.5          4.5
Keith R. Halls(10)                    --       --          1,361,022      1.9          1.9
Max L. Pinegar(11)                14,000        *                 --       --            *
Max E. Esplin(12)                 14,000        *                 --       --            *
Daniel W. Campbell                    --       --                 --       --           --
E.J. "Jake" Garn                      --       --                 --       --           --
Paula Hawkins                         --       --                 --       --           --
Renn M. Patch(13)                 14,000        *                 --       --            *
Michael D. Smith(14)              14,000        *                 --       --            *
Takashi Bamba(15)                 13,000        *                 --       --            *
John Chou(16)                     13,215        *                 --       --            *
BNASIA, Ltd(17)                       --       --         20,452,884     28.5         28.1
RCKASIA, Ltd(18)                      --       --          4,850,736      6.8          6.7
All directors and officers as    358,373      2.7         41,537,737     57.9         56.9
a group (19 persons)(19)
- ------------------------ *Less than 1% (1) Each share of Class B Common Stock is convertible at any time at the option of the holder into one share of Class A Common Stock and each share of Class B Common Stock is automatically converted into one share of Class A Common Stock upon the transfer of such share of Class B Common Stock to any person who is not a Permitted Transferee as defined in the Stockholders Agreement entered into by the Company and certain of its stockholders prior to the Company's initial public offering. (2) Includes shares beneficially owned or deemed to be owned beneficially by Blake M. Roney as follows: 20,452,884 shares of Class B Common Stock as general partner of BNASIA, Ltd., a limited partnership, and with respect to which he shares voting and investment power with his wife Nancy L. Roney as set forth in footnote 17 below; and 176,165 shares of Class B Common Stock as trustee and with respect to which he has sole voting and investment power. Blake M. Roney is the Chairman of the Board of Directors of the Company and Chairman of the Board of Directors, an executive officer and a shareholder of NSI. (3) Includes shares beneficially owned or deemed to be owned beneficially by Nedra D. Roney as follows: 14,213,895 shares of Class B Common Stock directly and with respect to which she has sole voting and investment power. Nedra D. Roney is a Director and shareholder of NSI. (4) Includes shares beneficially owned or deemed to be owned beneficially by Sandie N. Tillotson as follows: 7,634,743 shares of Class B Common Stock directly and with respect to which she has sole voting and investment power; 424,767 shares of Class B Common Stock as trustee and with respect to which she has sole voting and investment power; and 500,000 shares of Class B Common Stock as manager of a limited liability company and with respect to which she has sole voting and investment power. Sandie N. Tillotson is a Director of the Company and a Director, executive officer and shareholder of NSI. (5) Includes shares beneficially owned or deemed to be owned beneficially by Craig S. Tillotson as follows: 3,032,912 shares of Class B Common Stock directly and with respect to which he has sole voting and investment power; 112,500 shares of Class B Common Stock as trustee and with respect to which he has sole voting and investment power; 265,645 shares of Class B Common Stock as co-trustee and with respect to which he shares voting and investment power; and 1,000,000 shares of Class B Common Stock as manager of a limited liability company and with respect to which he has sole voting and investment power. Craig S. Tillotson is a shareholder of NSI. (6) Includes shares beneficially owned or deemed to be owned beneficially by R. Craig Bryson as follows: 4,850,736 shares of Class B Common Stock as general partner of RCKASIA, Ltd., a limited partnership, and with respect to which he shares voting and investment power with his wife Kathleen D. Bryson as set forth in footnote 18 below; and 75,000 shares of Class B Common Stock as co-trustee and with respect to which he shares voting and investment power with Kathleen D. Bryson. R. Craig Bryson is a shareholder of NSI. (7) Includes shares beneficially owned or deemed to be owned beneficially by Steven J. Lund as follows: 3,271,752 shares of Class B Common Stock as general partner of a limited partnership and with respect to which he shares voting and investment power with his wife Kalleen Lund; 897,901 shares of Class B Common Stock as trustee and with respect to which he has sole voting and investment power; and 75,000 shares of Class B Common Stock as co-trustee and with respect to which he shares voting and investment power with Kalleen Lund. Steven J. Lund is a Director and President of the Company and a Director, executive officer and shareholder of NSI. (8) Includes shares beneficially owned or deemed to be owned beneficially by Brooke B. Roney as follows: 3,496,752 shares of Class B Common Stock as general partner of a limited partnership and with respect to which he shares voting and investment power with his wife Denice R. Roney. Brooke B. Roney is a Director of the Company and a Director, executive officer and shareholder of NSI. (9) Includes shares beneficially owned or deemed to be owned beneficially by Kirk V. Roney as follows: 3,171,752 shares of Class B Common Stock as general partner of a limited partnership and with respect to which he shares voting and investment power with his wife Melanie K. Roney; and 75,000 shares of Class B Common Stock as co-trustee and with respect to which he shares voting and investment power with Melanie K. Roney and Lee S. McCullough. Kirk V. Roney is a Director of the Company and a Director, executive officer and shareholder of NSI. (10) Includes shares beneficially owned or deemed to be owned beneficially by Keith R. Halls as follows: 593,758 shares of Class B Common Stock as general partner of a limited partnership and with respect to which he shares voting and investment power with his wife Anna Lisa Massaro Halls; 50,000 shares of Class B Common Stock as the manager of a limited liability company and with respect to which he has sole voting and investment power; 704,764 shares of Class B Common Stock as trustee and with respect to which he has sole voting and investment power; and 12,500 shares of Class B Common Stock as co-trustee and with respect to which he shares voting and investment power with Anna Lisa Massaro Halls. Keith R. Halls is a Director and Secretary of the Company and a Director, executive officer and shareholder of NSI. (11) Includes shares beneficially owned or deemed to be owned beneficially by Max L. Pinegar as follows: 1,000 shares of Class A Common Stock directly and with respect to which he has sole voting and investment power; and 13,000 shares of Class A Common Stock issued to Mr. Pinegar as an employee stock bonus award which will vest ratably, according to its terms, over four years following the date of the award. Max L. Pinegar is a Director of the Company and an executive officer of NSI. (12) Includes shares beneficially owned or deemed to be owned beneficially by Max E. Esplin as follows: 1,000 shares of Class A Common Stock directly and with respect to which he has sole voting and investment power; and 13,000 shares of Class A Common Stock issued to Mr. Esplin as an employee stock bonus award which will vest ratably, according to its terms, over four years following the date of the award. Max E. Esplin is a Director of the Company and an executive officer of NSI. (13) Includes shares beneficially owned or deemed to be owned beneficially by Renn M. Patch as follows: 1,000 shares of Class A Common Stock directly and with respect to which he has sole voting and investment power; and 13,000 shares of Class A Common Stock issued to Mr. Patch as an employee stock bonus award which will vest ratably, according to its terms, over four years following the date of the award. Renn M. Patch is Chief Operating Officer of the Company and an executive officer of NSI. (14) Includes shares beneficially owned or deemed to be owned beneficially by Michael D. Smith as follows: 1,000 shares of Class A Common Stock directly and with respect to which he has sole voting and investment power; and 13,000 shares of Class A Common Stock issued to Mr. Smith as an employee stock bonus award which will vest ratably, according to its terms, over four years following the date of the award. Michael D. Smith is Vice President of Operations of the Company. (15) Includes shares beneficially owned or deemed to be owned beneficially by Takashi Bamba as follows: 13,000 shares of Class A Common Stock issued to Mr. Bamba as an employee stock bonus award which will vest ratably, according to its terms, over four years following the date of the award. Takashi Bamba is President of Nu Skin Japan. (16) Includes shares beneficially owned or deemed to be owned beneficially by John Chou as follows: 215 shares of Class A Common Stock directly and with respect to which he has sole voting and investment power; and 13,000 shares of Class A Common Stock issued to Mr. Chou as an employee stock bonus award which will vest ratably, according to its terms, over four years following the date of the award. John Chou is President of Nu Skin Taiwan. (17) Includes 20,452,884 shares of Class B Common Stock owned by BNASIA, Ltd., a limited partnership of which Blake M. Roney and his wife Nancy L. Roney are the general partners and who share voting and investment power. (18) Includes 4,850,736 shares of Class B Common Stock owned by RCKASIA, Ltd., a limited partnership of which R. Craig Bryson and his wife Kathleen D. Bryson are the general partners and who share voting and investment power. (19) Class A Common Stock includes: 250,825 shares subject to a stock option which has been granted to an executive officer of the Company and which is exercisable until January 1, 2004; 5,748 shares owned directly by certain directors and executive officers; and 101,800 shares issued to certain directors and executive officers as employee stock bonus awards which will vest ratably, according to their terms, over four years following the date of the awards. COMPLIANCE WITH SECTION 16(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Section 16(a) of the Securities Exchange Act of 1934, as amended, requires the Company's officers and directors and persons who own beneficially more than 10% of a registered class of the Company's equity securities to file with the Securities and Exchange Commission and the New York Stock Exchange initial reports of ownership and reports of changes in ownership of the Company's equity securities. Officers, directors and greater than 10% beneficial owners are required to furnish the Company with copies of all Section 16(a) reports they file. Based solely upon a review of the copies of such reports furnished to the Company and written representations that no other reports were required, the Company believes that during the fiscal year ended December 31, 1996 the Company's officers, directors and greater than 10% beneficial owners complied with all applicable Section 16(a) filing requirements, except that Messrs. John Chou, S.T. Han and George Mak each inadvertently filed one report, relating to one transaction, after its due date. COMPENSATION OF DIRECTORS AND EXECUTIVE OFFICERS The Company believes that stockholders should be provided information about director and executive officer compensation consistent with the rules of the Securities and Exchange Commission. As a result, this Proxy Statement contains the following sections of information regarding executive compensation: Summary Compensation Table; Employment Agreements; 1996 Stock Incentive Plan; Bonus Incentive Plan; Compensation Committee Interlocks and Insider Participation; Executive Compensation Report of the Board of Directors; and Stock Performance Graph. Summary Compensation Table The following table sets forth a summary of all compensation awarded or paid to or earned by the chief executive officer and the four other most highly compensated executive officers of the Company in the last fiscal year for services rendered in all capacities to the Company for the fiscal years ended December 31, 1995 and 1996. Except for the employee stock bonus awards referenced elsewhere herein, no options or long-term incentive plan awards were granted or made to the referenced executive officers during the referenced periods, except as provided below. The Company was formed in September 1996, and consequently paid no compensation to the executive officers named in the table below during the fiscal year ended December 31, 1995 and during the first eight months of the fiscal year ended December 31, 1996. However, salary, bonus and other compensation is presented in the table below for 1995 and 1996 based on payments by NSI and the Subsidiaries and, for the last quarter of 1996, by the Company to the named executive officers as if the Company had been in existence during all of 1995 and 1996. During 1995 and 1996, Messrs. Bamba and Chou were, and continue to be, employed full time as the General Managers and/or Presidents of Nu Skin Japan and Nu Skin Taiwan, respectively, and received all of their compensation from the Company through these Subsidiaries. During 1995 and 1996, Messrs. Lund, Smith and Patch were, and Messrs. Lund and Patch continue to be, executive officers of NSI. The compensation presented in the table below reflects an allocation of the time spent by Messrs. Lund, Smith and Patch providing services to the Company and the Subsidiaries during 1995 and 1996. These salaries and bonuses are in addition to any amounts received by these officers from NSI in return for their services to NSI. Annual Compensation --------------------------------------------------------------------------- Other Annual All Other Name and Principal Position Year Salary Bonus Compensation Compensation - --------------------------- ---- ------ ----- ------------ ------------ Steven J. Lund......................... 1996 $259,973 $89,345(1) $ -- $ -- President and Chief 1995 236,364 82,529(1) -- -- Executive Officer Takashi Bamba.......................... 1996 364,138 174,557(2) 195,401(3) 3,297(4) President, Nu Skin Japan 1995 361,028 105,563(2) 98,063(3) 3,297(4) John Chou.............................. 1996 211,000 56,232(2) 77,897(5) -- President, Nu Skin 1995 185,370 75,786(2) 63,730(5) -- Taiwan Michael D. Smith....................... 1996 157,812 13,090(1) 25,676(6) 24,390(7) Vice President of 1995 -- -- -- -- Operations Renn M. Patch.......................... 1996 98,638 20,437(1) 13,800 5,542(7) Chief Operating Officer 1995 97,175 104,765(8) 18,750(9) --
- --------------------------- (1) Cash bonus paid to the recipient not pursuant to a formal bonus plan. (2) Cash bonus paid during the year reported pursuant to a cash bonus long- term incentive plan for the Presidents of the Subsidiaries. (3) Includes deferred portion of a bonus accrued during the year reported pursuant to a cash bonus long-term incentive plan for the Presidents of the Subsidiaries and annual lease payments for an automobile. (4) Annual premium for pension insurance policy. (5) Includes deferred portion of a bonus accrued during the year reported pursuant to a cash bonus long-term incentive plan for the Presidents of the Subsidiaries and annual payments for an automobile and club dues. (6) Includes deferred portion of a bonus accrued during the year reported not pursuant to a formal bonus plan. (7) Includes compensation in the form of the cash value of the use of certain NSI-owned property and other perquisites. (8) Noncash bonus paid to Mr. Patch, not pursuant to a formal bonus plan. (9) Includes $16,500 of accrued deferred compensation and $2,250 of vested deferred compensation awarded to Mr. Patch under NSI's deferred compensation plan. Employment Agreements Messrs. Bamba, Chou and Han have entered into employment agreements with Nu Skin Japan, Nu Skin Taiwan and Nu Skin Korea, respectively. Under these agreements, these individuals are paid an annual salary and receive various other benefits. These individuals, together with Mr. Mak, are also entitled to participate in a cash bonus long-term incentive plan. Mr. Bamba is employed as the President of Nu Skin Japan at a 1977 annual salary of approximately $394,000. This salary is subject to annual review. Under the terms of his employment agreement, Mr. Bamba is entitled to reimbursement of business-related expenses, the use of an automobile provided by Nu Skin Japan, and participation in any retirement plan offered by Nu Skin Japan. Mr. Bamba also has the right under his employment agreement to have Nu Skin Japan purchase a country club membership and pay related dues, although he has not exercised this right. Mr. Bamba is also provided with a private insurance plan paid for by Nu Skin Japan provided the premium for such private insurance plan does not exceed (Y)300,000 per year. Under his employment agreement, Mr. Bamba has agreed to certain confidentiality obligations. The term of Mr. Bamba's employment is indefinite, subject to termination by Mr. Bamba or Nu Skin Japan upon three months' notice. Mr. Chou is employed as the President of Nu Skin Taiwan at a 1977 annual salary of approximately $230,000. Under the terms of his employment agreement, Mr. Chou is entitled to health insurance paid for in part by Nu Skin Taiwan. Nu Skin Taiwan also provides Mr. Chou with a monthly car allowance. The term of Mr. Chou's employment agreement currently extends until June 1997. Under his employment agreement, Mr. Chou has agreed to certain confidentiality obligations. Mr. Han is employed as the President of Nu Skin Korea at a 1977 annual salary of approximately $140,000. Under the terms of his employment agreement, Mr. Han is entitled to the use of an automobile and driver provided by Nu Skin Korea, as well as medical insurance and pension benefits. Mr. Han's employment is for a three year term ending January 1, 1999, subject to the right of Nu Skin Korea or Mr. Han to terminate the agreement on 60 days' advance notice. Once Mr. Han had been employed by Nu Skin Korea for 12 months, he became entitled to receive, upon termination, severance pay equal to two months' salary for each consecutive year of service. Under his employment agreement, Mr. Han has agreed to certain confidentiality and noncompetition obligations. 1996 Stock Incentive Plan The Board of Directors has adopted the Nu Skin Asia Pacific, Inc. 1996 Stock Incentive Plan. The purpose of the Plan is to attract and retain executives, other employees, independent consultants and directors who are important to the success and growth of the Company. A summary of the material terms of the Plan, a copy of which is attached hereto as Exhibit A, is set forth above in "Item 2 -- Approval of Adoption of the Nu Skin Asia Pacific, Inc. 1996 Stock Incentive Plan." Bonus Incentive Plan The Company has adopted a bonus incentive plan for the Presidents of the Subsidiaries. This bonus incentive plan is patterned after a similar plan under which Messrs. Bamba, Chou, Han and Mak were compensated prior to the Company's initial public offering. Under the new bonus incentive plan, Messrs. Bamba, Chou, Han and Mak are entitled to receive an annual cash bonus based upon the prior year's operating results of the Subsidiary for which they are responsible. Participants in this bonus incentive plan are able to receive a bonus equal to 100% of their respective salaries, conditioned on meeting certain performance criteria and subject to cash availability and approval of the Board of Directors of the Company. One half of this bonus is payable by February 15 of the year following the year in which the bonus is earned and the remaining one half is deferred and vests ratably over 10 years or at age 65, whichever occurs first. Compensation Committee Interlocks and Insider Participation Several members of the Company's Board of Directors are also directors of NSI and have set or will set compensation for certain executive officers of the Company who have been or may in the future be executive officers of NSI. Executive Compensation Report of the Board of Directors The Compensation Committee was not formed until March 1997. Accordingly, the Board of Directors performed the functions of the Compensation Committee for the fiscal year ended December 31, 1996. Notwithstanding anything to the contrary set forth in any of the previous filings made by the Company under the Securities Act of 1933, as amended, or the Securities Act of 1934, as amended, that might incorporate future filings, including, but not limited to, this Proxy Statement, in whole or in part, the following Executive Compensation Report and the performance graph appearing herein shall not be deemed to be incorporated by reference into any such future filings. This Executive Compensation Report discusses the Company's executive compensation policies and the basis for the compensation paid to the Company's executive officers, including its Chief Executive Officer, Steven J. Lund, during the fiscal year ended December 31, 1996. Compensation Policy. The Company's policy with respect to executive compensation has been designed to: o Adequately and fairly compensate executive officers in relation to their responsibilities, capabilities and contributions to the Company and in a manner that is commensurate with compensation paid by companies of comparable size or within the Company's industry; o Reward executive officers for the achievement of short-term operating goals and for the enhancement of the long-term value of the Company; and o Align the interests of the executive officers with those of the Company's stockholders with respect to short-term operating goals and long-term increases in the price of the Company's Common Stock. The components of compensation paid to certain executive officers consist of: (a) base salary, (b) incentive compensation in the form of annual bonus payments and other awards made by the Company under the Company's bonus incentive plans for the Presidents of the Subsidiaries and the Nu Skin Asia Pacific, Inc. 1996 Stock Incentive Plan, respectively, and (c) certain other benefits provided to the Company's executive officers. In the absence of a Compensation Committee, the Board of Directors has been responsible for reviewing and approving cash compensation paid by the Company to its executive officers and members of the Company's senior management team, including annual bonuses and awards made under the aforementioned incentive plans, selecting the individuals who will receive such bonuses and awards and determining the timing, pricing and amount of all such bonuses and awards granted. As described above, the Company has adopted a bonus incentive plan for the Presidents of the Subsidiaries. The Company has not yet adopted a formal bonus incentive plan for other executive officers. During 1996, bonuses made to executive officers other than the Presidents of the Subsidiaries were discretionary and based on achievement of business targets and objectives. The Company believes its incentive compensation plan for Presidents of the Subsidiaries rewards those officers when the Company and its stockholders have benefited from achieving the Company's goals and targeted objectives, all of which the Board of Directors feels will dictate, in large part, the Company's future operating results. The Board of Directors believes that its policy of compensating certain of its executive officers with incentive-based compensation fairly and adequately compensates those individuals in relation to their responsibilities, capabilities and contribution to the Company, and in a manner that is commensurate with compensation paid by companies of comparable size or within the Company's industry. Components of Compensation. The primary components of compensation paid by the Company to its executive officers and senior management personnel, and the relationship of such components of compensation to the Company's performance, are discussed below: Base Salary. For the fiscal year ended December 31, 1996, the Board of Directors reviewed and approved the base salary paid by the Company to its executive officers and the Presidents of the Subsidiaries. Annual adjustments to base salaries are determined based upon a number of factors, including the Company's performance (to the extent such performance can fairly be attributed or related to each executive's officer's performance), as well as the nature of each executive officer's responsibilities, capabilities and contributions. In addition, for the fiscal year ended December 31, 1996, the Board of Directors reviewed the base salaries of its executive officers in an attempt to ascertain whether those salaries fairly reflect job responsibilities and prevailing market conditions and rates of pay. The Board of Directors believes that base salaries for the Company's executive officers have been reasonable in relation to the Company's size and performance in comparison with the compensation paid by similarly sized companies or companies within the Company's industry. Incentive Compensation. As discussed above, a substantial portion of the compensation paid to the Presidents of the Subsidiaries is in the form of incentive compensation designed to reward the achievement of operating goals and long-term increases in shareholder value. Under the terms of the bonus incentive plan for the Presidents of the Subsidiaries and the Nu Skin Asia Pacific, Inc. 1996 Stock Incentive Plan, the Board of Directors and the Compensation Committee have authority, within the terms of such plans, to select the executive officers and employees who will be granted bonuses and other awards and to determine the timing, pricing and amount of any such bonuses or awards. Other Benefits. The Company maintains certain other plans and arrangements for the benefit of its executive officers. The Company believes these benefits are reasonable in relation to the executive compensation practices of other similarly sized companies or companies within the Company's industry. Compensation of the Chief Executive Officer. Steven J. Lund, the Company's President and Chief Executive Officer, is also Executive Vice President of NSI and an officer of certain other NSI affiliates. During 1995 and 1996, even after the Company's formation in September 1996, Mr. Lund continued to receive all of his cash compensation from NSI. This practice will likely continue during 1997. The amounts set forth in the table above reflect that portion of Mr. Lund's salary and bonus which is allocated to the Company based on the relative amount of time spent on the Company's affairs. Conclusion. The Board of Directors believes that the concepts discussed above further the stockholders' interests and that officer compensation encourages responsible management of the Company. The Board of Directors regularly considers the effect of management compensation on stockholder interests. In the past, the Board of Directors based its review on the experience of its own members and on information requested from management personnel. In the future, these factors, reports of the Compensation Committee and discussions with and information compiled by various independent consultants retained by the Company will be used in determining officer compensation. Board of Directors(1) Blake M. Roney Steven J. Lund Sandie N. Tillotson Brooke B. Roney Kirk V. Roney Keith R. Halls Max E. Esplin Max L. Pinegar - ----------------- (1) For the fiscal year ended December 31, 1996, the entire Board of Directors then serving acted as the Compensation Committee. A Compensation Committee consisting of Keith R. Halls, Max L. Pinegar, Paula Hawkins and Daniel W. Campbell was established on March 3, 1997. In addition, on that date E. J. "Jake" Garn, Paula Hawkins and Daniel W. Campbell were appointed to the Board of Directors. Stock Performance Graph The following graph compares the cumulative total stockholder return (stock price appreciation plus dividends) on the Company's Class A Common Stock with the cumulative total return of the S&P 500 Index and a market weighted index of publicly traded peers for the period from November 21, 1996 (the date the Class A Common Stock was priced in connection with the Company's initial public offering) though December 31, 1996. The returns are calculated by assuming an investment in the Class A Common Stock and each index of $100 on November 21, 1996. The publicly traded companies in the peer group are: Amway Asia Pacific, Ltd., Amway Japan, Ltd., The Estee Lauder Companies, Inc., Tupperware Corporation, Revlon, Inc. and Avon Products. Measurement Period Company S&P 500 Index Peer Group Index ------------------ ------- ------------- ---------------- November 21, 1996 $100.00 $100.00 $100.00 December 31, 1996 102.49 99.90 97.11 [Stock Performance Graph] CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS The Reorganization Prior to the Company's initial public offering, the shareholders of Nu Skin Japan, Nu Skin Taiwan, Nu Skin Korea, Nu Skin Hong Kong and Nu Skin Personal Care (Thailand) Limited contributed their shares of capital stock to the capital of the Company in a transaction intended to qualify under Section 351 of the Internal Revenue Code of 1986, as amended, in exchange for shares of the Company's Class B Common Stock (the "Reorganization"). As a result of the Reorganization, each of the Subsidiaries became a wholly-owned subsidiary of the Company, and all of the outstanding shares of Class B Common Stock are now held by these shareholders (the "Original Stockholders") and certain of their affiliates. S Corporation Distribution Prior to the Reorganization, each Subsidiary elected to be treated as an "S" corporation under Subchapter S of the Code and comparable state tax laws. On November 19, 1996, the Subsidiaries' S corporation status was terminated (the "S Termination Date"). Prior to the S Termination Date, the Company declared a distribution to the Original Stockholders that included all of the Subsidiaries' previously earned and undistributed S corporation earnings through the S Termination Date (the "S Corporation Distribution"). As of the date of the Reorganization, the Subsidiaries' aggregate undistributed taxable S corporation earnings were $86.5 million. The S Corporation Distribution was distributed in the form of promissory notes, which are expected to be paid during 1997, bearing interest at 6% per annum (the "S Distribution Notes"). From the proceeds of the Company's initial public offering, $15.0 million was used to pay a portion of the S Distribution Note balance of $71.5 million at December 31, 1996. Control By Original Stockholders As of March 3, 1997, approximately 98.4% of the combined voting power of the outstanding shares of Common Stock was held by the Original Stockholders and certain of their affiliates. Consequently, as of such date, the Original Stockholders and certain of their affiliates had the ability, acting in concert, to elect all directors of the Company and approve any action requiring approval by a majority of the stockholders of the Company. As of March 3, 1997, certain of the Original Stockholders also owned 100% of the outstanding shares of NSI. As a result of this ownership, these Original Stockholders will consider the short-term and the long-term impact of all stockholder decisions on the consolidated financial results of NSI and the Company. The interests of NSI, on the one hand, and of the Company, on the other hand, may differ from time to time. Operating Agreements; Relationship with NSI NSI has licensed to the Company, through the Subsidiaries, rights to distribute NSI products and to use certain NSI property in the Company's markets, and an NSI affiliate, Nu Skin International Management Group, Inc. ("NSIMG"), provides management support services to the Company and the Subsidiaries, pursuant to distribution, trademark/tradename license, licensing and sales, and management services agreements with the Subsidiaries (collectively, the "Operating Agreements"). Virtually all of the products sold by the Company are purchased from NSI pursuant to distribution agreements. The Company also manufactures itself, or through third-party manufacturers, certain products and commercial materials which it then sells using NSI trademarks or tradenames licensed under trademark/tradename license agreements. In addition, the Company does not have its own sales or distribution network but licenses the right to use NSI's distribution network and global distributor compensation plan pursuant to licensing and sales agreements. NSIMG also provides a broad range of management, administrative and technical support to the Company pursuant to management services agreements. During the fiscal year ended December 31, 1996, NSI and NSIMG charged the Company approximately $219.9 million and $4.2 million, respectively, for goods and services provided to the Company under the Operating Agreements. The Operating Agreements were approved by the original Board of Directors of the Company, which was composed entirely of officers and shareholders of NSI. In addition, two of the executive officers of the Company, including the Chief Executive Officer, are also executive officers of NSI. It is expected that they will continue to spend a portion of their time on the affairs of NSI, for which they will continue to receive compensation from NSI, in addition to amounts received from the Company for services to the Company. During 1996, Nu Skin Japan paid NSI a royalty of 8% of the revenue from sales of products manufactured by a third party manufacturer under a license agreement between Nu Skin Japan and NSI. In the fiscal year ended December 31, 1996, Nu Skin Japan paid NSI $2.9 million in royalties under this agreement. Pursuant to wholesale distribution agreements, Nu Skin Hong Kong distributes certain NSI products to Nu Skin Personal Care Australia, Inc. and Nu Skin New Zealand, Inc., affiliates of NSI. Pursuant to these agreements, Nu Skin Hong Kong was paid approximately $4.6 million in fiscal year 1996 by Nu Skin Personal Care Australia, Inc. and Nu Skin New Zealand, Inc. Concurrently with the Company's initial public offering, the Company purchased from NSI for $25 million, the exclusive rights to distribute NSI products in Thailand, Indonesia, Malaysia, the Philippines, the People's Republic of China, Singapore and Vietnam. As of March 3, 1997, the Company had paid $15 million of this amount. In addition, the Company and NSI have entered into a mutual indemnification agreement pursuant to which NSI has agreed to indemnify the Company for certain claims, losses and liabilities relating to the operations of the Subsidiaries prior to the Reorganization, and the Company has agreed to indemnify NSI for certain claims, losses and liabilities relating to the operations of the Subsidiaries after the Reorganization. Stockholders' Partnership Craig Bryson and Craig S. Tillotson are major stockholders of the Company and have been NSI distributors since 1984. Messrs. Bryson and Tillotson are partners in an entity (the "Partnership") which receives substantial commissions from NSI, including commissions on sales generated within the Company's markets. For the fiscal year ended December 31, 1996, total commissions paid to the Partnership on sales originating in the Company's then open markets (Japan, Taiwan, Hong Kong and South Korea) were approximately $1.2 million. By agreement, NSI pays commissions to the Partnership at the highest level of commissions available to distributors. Management believes that this arrangement allows Messrs. Bryson and Tillotson the flexibility of using their expertise and reputations in network marketing circles to sponsor, motivate and train distributors to benefit NSI's distributor force generally, without having to focus solely on their own organizations. Stockholders' Agreement The Original Stockholders have entered into a stockholders' agreement with the Company (the "Stockholders' Agreement"). As of March 3, 1997, the Original Stockholders and certain of their affiliates beneficially owned shares having approximately 98.4% of the combined voting power of the outstanding shares of Common Stock. In order to ensure the qualification of the Reorganization under Section 351 of the Code, the Original Stockholders have agreed not to transfer any shares they own through November 28,1997 without the consent of the Company except for certain transfers relating to the funding of the Distributor Options and the grant of the employee stock bonus awards. After such date and subject to any volume limitations imposed by Rule 144 under the Securities Act of 1933, as amended, no such stockholder is permitted to transfer in any one-year period a number of shares equal to the greater of (i) 10% of the total number of shares of Common Stock originally issued to such stockholder in connection with the Reorganization, or (ii) 1.25% of the total Common Stock issued and outstanding at the time of such proposed transfer. The Original Stockholders have been granted registration rights by the Company permitting each such Original Stockholder to register his or her shares of Class A Common Stock, subject to certain restrictions, on any registration statement filed by the Company until such Original Stockholder has sold a specified value of shares of Class A Common Stock. Agreements and Arrangements with Management Prior to the Company's initial public offering, the Company entered into indemnification agreements with its officers and directors indemnifying them against liability incurred by them in the course of their service to the Company. Pursuant to the Nu Skin Asia Pacific, Inc. 1996 Stock Incentive Plan, and as set forth in "Item 2 -- Approval of Adoption of the Nu Skin Asia Pacific, Inc. 1996 Stock Incentive Plan," as of March 3, 1997, the Company had granted stock bonus awards to certain executive officers of the Company for an aggregate of 150,959 shares of Class A Common Stock. The shares of Class A Common Stock underlying each of these stock bonus awards will be issued to the recipient of the award at a rate of 25% per year commencing in November 1997, subject to certain restrictions. In January 1994, NSI stockholders agreed to grant to an individual who is now an executive officer of the Company an option, which became immediately exercisable upon consummation of the Reorganization, to purchase 267,500 shares of Class A Common Stock at an aggregate exercise price of $500,000, which reflects the agreed upon fair market value of this equity interest in January 1994. As of March 3, 1997, the executive officer had exercised a portion of this option and purchased 16,675 shares of Class A Common Stock, which he then sold in the Company's initial public offering. The Company has employment agreements with certain of its executive officers, as set forth in "Compensation of Directors and Executive Officers -- Employment Agreements." Distributor Options Prior to the Company's initial public offering, the Original Stockholders converted 1,605,000 shares of Class B Common Stock into Class A Common Stock and contributed such shares to the Company for use in implementing an NSI distributor equity incentive program, and the Company granted to NSI an option to acquire such 1,605,000 shares of Class A Common Stock (the Distributor Options). NSI will assign the Distributor Options to qualifying distributors of NSI in connection with the Company's non-underwritten offering which commenced in connection with the Company's initial public offering (the Rule 415 Offerings). The Distributor Options are subject to certain conditions related to distributor performance and will vest on December 31, 1997. The Company will record distributor incentive expense for the Distributor Options. INTEREST OF CERTAIN PERSONS IN MATTERS TO BE ACTED UPON The Board of Directors has approved stock bonus awards to certain executive officers of the Company. See "Item 3 -- Approval of Adoption of the Nu Skin Asia Pacific, Inc. 1996 Stock Incentive Plan." ANNUAL REPORT TO STOCKHOLDERS The Annual Report to Stockholders concerning the operation of the Company for the fiscal year ending December 31, 1996, including financial statements, is enclosed herewith. ANNUAL REPORT TO SECURITIES AND EXCHANGE COMMISSION A copy of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 1996, as filed with the Securities and Exchange Commission, without exhibits may be obtained by stockholders without charge by written request to Charles N. Allen, Nu Skin Asia Pacific, Inc., 75 West Center Street, Provo, Utah 84601. Exhibits will be provided upon written request and payment of an appropriate processing fee. By Order of the Board of Directors Blake M. Roney Chairman of the Board DATED: April 7, 1997